Bit surprised, wasn't expecting an interim report. Haven't seen drusen improve nor retinal sensitivity increase, spontaneously. Hmmm. Too early to assess progression, time will tell. Patience required, but feeling optimistic. If I recall Dr Fletcher has a grant to study the phenomenon in more detail, wonder how that is going.
Ann: Ellex Announces Interim Review for 2RT Clinical Trial-ELX.AX, page-4
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.64M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 15.5¢ | $65.26K | 412.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 76733 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 239407 | 5 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| EYE (ASX) Chart |